메뉴 건너뛰기
New England Journal of Medicine
Volumn 357, Issue 16, 2007, Pages 1662-
Anti-TNF antibodies for Crohn's disease [8]
Author keywords

[No Author keywords available]
Indexed keywords

CERTOLIZUMAB PEGOL; PLACEBO; TUMOR NECROSIS FACTOR ANTIBODY;
EID: 35348965093     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072381     Document Type: Letter
Times cited : (2)
References (3)
  • 1
    • 34447532097 scopus 로고    scopus 로고
    • Anti-TNF antibodies for Crohn's disease - in pursuit of the perfect clinical trial
    • Lewis JD. Anti-TNF antibodies for Crohn's disease - in pursuit of the perfect clinical trial. N Engl J Med 2007;357:296-8.
    • (2007) N Engl J Med , vol.357 , pp. 296-298
    • Lewis, J.D.1
  • 2
    • 34447523749 scopus 로고    scopus 로고
    • Certolizumab pegol for the treatment of Crohn's disease
    • Sandborn WJ, Feagan BG, Stoinov S, et al. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007;357:228-38.
    • (2007) N Engl J Med , vol.357 , pp. 228-238
    • Sandborn, W.J.1    Feagan, B.G.2    Stoinov, S.3
  • 3
    • 34447515607 scopus 로고    scopus 로고
    • Maintenance therapy with certolizumab pegol for Crohn's disease
    • Schreiber S, Khaliq-Kareemi M, Lawrance IC, et al. Maintenance therapy with certolizumab pegol for Crohn's disease. N Engl Med 2007;357:239-50.
    • (2007) N Engl Med , vol.357 , pp. 239-250
    • Schreiber, S.1    Khaliq-Kareemi, M.2    Lawrance, I.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.